AADI insider filings
Aadi Bioscience, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-03-05. Screen AADI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AADI between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Aadi Bioscience, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-05 | 4 | Dalal Anupam — Director | Grant/award (A): 1,561,000 @ $2.40 | EDGAR |
| 2025-03-04 | 4 | Zhao Baiteng — Director | Grant/award (A): 1,250,000 @ $2.40 | EDGAR |
| 2025-03-04 | 4 | Dornan David — Chief Scientific Officer | Grant/award (A): 687,979 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | BALL BRYAN — See remarks | Option exercise (M): 5,000 · Sale (S): 2,147 @ $2.35 · Grant/award (A): 100,000 @ $2.40 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Aghazadeh Behzad — Director, 10% owner Avoro Capital Advisors LLC — Director, 10% owner Avoro Ventures LLC — Director, 10% owner | Grant/award (A): 8,333,000 (derivative) @ $2.40 | EDGAR |
| 2025-03-04 | 4 | Castelein Caley — Director | Grant/award (A): 1,666,000 @ $2.40 | EDGAR |
| 2025-03-03 | 4 | Giacobello Scott M. — CHIEF FINANCIAL OFFICER | Option exercise (M): 6,750 · Sale (S): 2,806 @ $2.35 · Option exercise (M): 6,750 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Lennon David James — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 16,250 · Sale (S): 5,690 @ $2.35 · Option exercise (M): 16,250 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | Zhao Baiteng — Director | Grant/award (A): 61,192 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Lennon David James — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 32,558 @ $0 · Sale (S): 9,689 @ $1.94 · Option exercise (M): 32,558 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 40,000 @ $1.71 | EDGAR |
| 2024-08-05 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 15,415 @ $1.50 · Sale (S): 18,933 @ $1.41 · Sale (S): 5,652 @ $1.34 | EDGAR |
| 2024-07-02 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 31,348 @ $1.45 · Sale (S): 8,652 @ $1.34 | EDGAR |
| 2024-06-14 | 4 | Aghazadeh Behzad — Director, 10% owner Avoro Capital Advisors LLC — Director, 10% owner Avoro Ventures LLC — Director, 10% owner | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Hirmand Mohammad — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Reeve Emma — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Dalal Anupam — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Hehenberger Karin M. — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Maroun Richard E — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Castelein Caley — Director | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 19,775 @ $1.81 · Sale (S): 20,225 @ $1.77 | EDGAR |
| 2024-05-01 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 40,000 @ $1.93 | EDGAR |
| 2024-04-03 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 17,772 @ $2.31 · Sale (S): 22,228 @ $2.23 | EDGAR |
| 2024-03-04 | 4 | Lennon David James — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 30,768 (derivative) @ $0 · Grant/award (A): 130,000 (derivative) @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Desai Neil — EXECUTIVE CHAIRMAN, Director | Sale (S): 27,036 @ $1.97 · Sale (S): 14,964 @ $2.10 | EDGAR |
| 2024-03-04 | 4 | Giacobello Scott M. — CHIEF FINANCIAL OFFICER | Grant/award (A): 138,263 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | ITRI LORETTTA M — CHIEF MEDICAL OFFICER | Grant/award (A): 76,813 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 42,000 @ $1.74 | EDGAR |
| 2024-01-02 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 42,000 @ $2.06 | EDGAR |
| 2023-12-07 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 7,037 @ $4.82 | EDGAR |
| 2023-12-05 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 8,347 @ $5.14 · Sale (S): 10,876 @ $5.15 · Sale (S): 15,740 @ $5.02 | EDGAR |
| 2023-11-02 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 10,338 @ $4.32 · Sale (S): 31,662 @ $4.46 | EDGAR |
| 2023-10-03 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 25,569 @ $4.37 · Sale (S): 16,431 @ $4.10 | EDGAR |
| 2023-10-03 | 4 | Lennon David James — Chief Executive Officer, Director | Grant/award (A): 32,558 (derivative) @ $0 · Grant/award (A): 490,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 13,889 @ $5.97 · Sale (S): 21,000 @ $5.63 · Sale (S): 7,111 @ $5.29 | EDGAR |
| 2023-08-03 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 22,710 @ $5.22 · Sale (S): 19,290 @ $5.20 | EDGAR |
| 2023-07-06 | 4 | Desai Neil — Executive Chairman, Director | Sale (S): 10,000 @ $6.64 · Sale (S): 16,171 @ $6.55 · Sale (S): 15,829 @ $6.27 | EDGAR |
| 2023-06-20 | 4 | Aghazadeh Behzad — Director, 10% owner Avoro Capital Advisors LLC — Director, 10% owner Avoro Ventures LLC — Director, 10% owner | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Reeve Emma — Director | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Dalal Anupam — Director | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Hehenberger Karin M. — Director | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Maroun Richard E — Director | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Castelein Caley — Director | Grant/award (A): 28,255 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 7,260 @ $8.19 | EDGAR |
| 2023-06-05 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 4,982 @ $7.92 · Sale (S): 12,443 @ $7.99 · Sale (S): 17,315 @ $8.11 | EDGAR |
| 2023-05-05 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 2,305 @ $7.57 | EDGAR |
| 2023-05-03 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 24,479 @ $7.80 · Sale (S): 7,521 @ $7.48 · Sale (S): 7,695 @ $7.68 | EDGAR |
| 2023-04-06 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 12,212 @ $7.09 | EDGAR |
| 2023-04-05 | 4 | Desai Neil — Executive Chairman, Director, 10% owner | Sale (S): 9,583 @ $7.45 · Sale (S): 12,869 @ $7.30 · Sale (S): 7,336 @ $7.24 | EDGAR |
| 2023-04-04 | 4 | Giacobello Scott M. — CFO, Interim CEO & President | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aadi Bioscience, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AADI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →